Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts)
- PMID: 17989648
- DOI: 10.1038/sj.ki.5002655
Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts)
Abstract
Genetic engineering in the mouse has ushered in a new era of disease modeling that has advanced our understanding of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis. Historically, the major animal models of focal segmental glomerulosclerosis involve direct podocyte injury (exemplified by toxin models) and indirect podocyte injury due to adaptive responses (exemplified by renal ablation models). In both paradigms, recent evidence indicates that podocyte depletion is a major pathomechanism mediating proteinuria and glomerulosclerosis. Podocyte-specific toxin models support that podocyte loss is sufficient to cause focal segmental glomerulosclerosis in a dose-dependent manner. Knockout and transgenic models have provided proof of concept that mutations in specific podocyte proteins mediate genetic forms of focal segmental glomerulosclerosis. Transgenic models of HIV-associated nephropathy have helped to elucidate the role of direct viral infection and podocyte expression of viral gene products in the pathogenesis of this form of collapsing glomerulopathy. Taken together, emerging data support that injury directed to or inherent within the podocyte constitutes the critical event in diverse pathways to glomerulosclerosis.
Similar articles
-
HIV-associated nephropathy: experimental models.Contrib Nephrol. 2011;169:270-285. doi: 10.1159/000320212. Epub 2011 Jan 20. Contrib Nephrol. 2011. PMID: 21252526
-
Modulation of podocyte phenotype in collapsing glomerulopathies.Microsc Res Tech. 2002 May 15;57(4):254-62. doi: 10.1002/jemt.10084. Microsc Res Tech. 2002. PMID: 12012394
-
Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene.J Am Soc Nephrol. 2005 Oct;16(10):2941-52. doi: 10.1681/ASN.2005010055. Epub 2005 Aug 17. J Am Soc Nephrol. 2005. PMID: 16107576
-
Focal segmental glomerulosclerosis: recent advances.Curr Opin Nephrol Hypertens. 2008 Mar;17(2):138-42. doi: 10.1097/MNH.0b013e3282f5dbe4. Curr Opin Nephrol Hypertens. 2008. PMID: 18277145 Review.
-
Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.Acta Physiol Hung. 2015 Sep;102(3):241-51. doi: 10.1556/036.102.2015.3.2. Acta Physiol Hung. 2015. PMID: 26551740 Review.
Cited by
-
Identification of the vitamin D receptor in various cells of the mouse kidney.Kidney Int. 2012 May;81(10):993-1001. doi: 10.1038/ki.2011.463. Epub 2012 Jan 25. Kidney Int. 2012. PMID: 22278022 Free PMC article.
-
Brain natriuretic peptide mitigates TIMP2 induction and reinstates extracellular matrix catabolic activity via GSK3β inhibition in glomerular podocytes exposed to a profibrogenic milieu.Am J Transl Res. 2019 Feb 15;11(2):964-973. eCollection 2019. Am J Transl Res. 2019. PMID: 30899395 Free PMC article.
-
Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations.Clin Kidney J. 2014 Dec;7(6):531-7. doi: 10.1093/ckj/sfu100. Epub 2014 Sep 28. Clin Kidney J. 2014. PMID: 25503953 Free PMC article.
-
Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease.Dis Model Mech. 2021 Aug 1;14(8):dmm048952. doi: 10.1242/dmm.048952. Epub 2021 Aug 5. Dis Model Mech. 2021. PMID: 34350953 Free PMC article.
-
Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury.PLoS One. 2012;7(7):e41331. doi: 10.1371/journal.pone.0041331. Epub 2012 Jul 25. PLoS One. 2012. PMID: 22848465 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
